Treatment with a MEK inhibitor or a PI3K inhibitor has been shown to inhibit the growth of many types of cancer cells, including MPM cell lines, via induction of cell cycle arrest and apoptosis (14,15,23–25). Here, MAP2K7 is linked to cancer.